Passa al contenuto
Merck

Vai a

F6755

Fibrinogen from rat plasma

60-80% protein (≥60% of protein is clottable)

Sinonimo/i:

Factor I

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione
Voi/SKUDisponibilitàPrezzo
25 mg
Per conoscere la disponibilità, visualizza il carrello
CHF 753.00
100 mg
Per conoscere la disponibilità, visualizza il carrello
CHF 2510.00

Informazioni su questo articolo

Numero CAS:
UNSPSC Code:
12352202
EC Number:
232-598-6
NACRES:
NA.61
MDL number:
Form:
powder
Biological source:
rat plasma
Mol wt:
α-chain 63.5 kDa, β-chain 56 kDa, γ chain 47 kDa (about 4% carbohydrate content), soluble dimer 340 kDa

CHF 753.00


Per conoscere la disponibilità, visualizza il carrello

​
Richiedi un ordine personalizzato
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti


biological source

rat plasma

Quality Segment

form

powder

quality

60-80% protein (≥60% of protein is clottable)

mol wt

α-chain 63.5 kDa, β-chain 56 kDa, γ chain 47 kDa (about 4% carbohydrate content), soluble dimer 340 kDa

concentration

60-80% (biuret)

technique(s)

cell culture | mammalian: suitable, immunoblotting: suitable

UniProt accession no.

storage temp.

−20°C

Gene Information

Application

Fibrinogen from rat plasma has been used:
  • in the preparation of growth factor solutions
  • to apply on discontinuous SDS-polyacrylamide gels for the detection of IgG (immunoglobulins) type antibodies by immunoblot analysis
  • to mix with cell suspension to form a clot and retain the cells for avoiding its dispersion during transplantation

Fibrinogen has been used in studies of haemostatic therapy in surgical and massive trauma patients. These studies have shown that fibrinogen may prove to be more superior in stopping blood loss when compared to using fresh frozen plasma (FFP).

Biochem/physiol Actions

Acute phase protein that is part of the coagulation cascade of proteins.
Fibrinogen is an acute phase protein that is part of the coagulation cascade of proteins. The end result of the cascade is the production of thrombin that converts fibrinogen to fibrin. Thrombin rapidly proteolyses fibrinogen, releasing fibrinopeptide A. The loss of this small peptide is not sufficient to make the resulting fibrin molecule insoluble, but it tends to form complexes with adjacent fibrin and fibrinogen molecules. Thrombin then cleaves a second peptide, fibrinopeptide B, from fibrin and the fibrin monomers formed then polymerize spontaneously to form an insoluble gel. The polymerized fibrin is held together by noncovalent and electrostatic forces and stabilized by the transamidating enzyme, factor XIIIa, that is produced by the action of thrombin on factor XIII. The insoluble fibrin aggregates (clots) and aggregated platelets then block the damaged blood vessel and prevent further bleeding. The amount of fibrinogen in the plasma can serve as a nonspecific indicator of whether or not an inflammatory process is present in the body. Fibrinogen from any mammalian source will be cleaved by thrombin from any mammalian source.

Analysis Note

Contains ~12% sodium citrate and ~18% sodium chloride.
Protein determined by biuret.

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo
F3879F4883F8630
Fibrinogeno 50-70% protein (≥80% of protein is clottable)

Sigma-Aldrich

F3879

Fibrinogeno

Fibrinogeno 35-65% protein (≥90% of protein is clottable).

Sigma-Aldrich

F4883

Fibrinogeno

Fibrinogeno Type I-S, 65-85% protein (≥75% of protein is clottable)

Sigma-Aldrich

F8630

Fibrinogeno

description

60-80% protein (≥60% of protein is clottable)

description

50-70% protein (≥80% of protein is clottable)

description

35-65% protein (≥90% of protein is clottable).

description

Type I-S, 65-85% protein (≥75% of protein is clottable)

technique(s)

immunoblotting: suitable, cell culture | mammalian: suitable

technique(s)

ELISA: suitable

technique(s)

cell culture | mammalian: suitable

technique(s)

cell culture | mammalian: suitable

biological source

rat plasma

biological source

human plasma

biological source

human plasma

biological source

bovine plasma

concentration

60-80% (biuret)

concentration

50-70% protein (biuret)

concentration

35-65% protein (biuret)

concentration

65-85% (biuret)

form

powder

form

powder

form

powder

form

powder

mol wt

β-chain 56 kDa, γ chain 47 kDa (about 4% carbohydrate content), soluble dimer 340 kDa, α-chain 63.5 kDa

mol wt

β-chain 56 kDa, soluble dimer 340 kDa, γ chain 47 kDa (about 4% carbohydrate content), α-chain 63.5 kDa

mol wt

soluble dimer 340 kDa, γ chain 47 kDa (about 4% carbohydrate content), α-chain 63.5 kDa, β-chain 56 kDa

mol wt

γ chain 47 kDa (about 4% carbohydrate content), β-chain 56 kDa, α-chain 63.5 kDa, soluble dimer 340 kDa

Gene Information

rat ... Fga(361969), Fgb(24366), Fgg(24367)

Gene Information

human ... FGA(2243), FGB(2244), FGG(2266)

Gene Information

human ... FGA(2243), FGB(2244), FGG(2266)

Gene Information

cow ... FGA(522039), FGB(510522), FGG(280792)


Classe di stoccaggio

11 - Combustible Solids

Che succede?

WGK 3

Punto di infiammabilità (°F)

Not applicable

Punto di infiammabilità (°C)

Not applicable

DPI (dispositivi di protezione individuale)

Eyeshields, Gloves, type N95 (US)



Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti




Questions

Reviews

No rating value

Active Filters